Antireflux Ureteral Stent Improves Stent-Related Symptoms and Quality of Life: A Prospective Randomized Controlled Trial
Journal of Endourology · 2023
DOI: 10.1089/end.2022.0839 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Endourology, 2023. Verfasst von Yuqing Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China. Hauptthemen laut MEDLINE: Ureteral Calculi, Hydronephrosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objectives
To compare the effectiveness of antireflux ureteral stents on improving symptoms and quality of life of patients with ureteral stents. Materials and Methods: We randomized 120 patients with ureteral stone who required ureteral stent placement after ureteroscopic lithotripsy, of which 107 (56 in standard ureteral stent group and 51 in antireflux ureteral stent group) entered the final analysis. Severity of flank pain and suprapubic pain, visual analog scale (VAS), analgesic used after hospitalization, back soreness during micturition, gross hematuria, creatinine abnormality, hydronephrosis grade, symptomatic urinary tract infection (UTI), and quality of life were compared between the two groups.
Results
There were no serious complications after operation in all 107 cases. The antireflux ureteral stent group had less flank pain and suprapubic pain (p < 0.05), analgesic used after hospitalization (p < 0.05), back soreness during micturition (p < 0.05), and lower VAS (p < 0.05). The health status index scores (p < 0.05), dimensions of usual activities, and pain/discomfort (p < 0.05) in the antireflux ureteral stent group were statistically better than those in the standard ureteral stent group. There were no significant differences between the groups in creatinine abnormality, hydronephrosis grade, gross hematuria, and symptomatic UTI.
Conclusions
The antireflux ureteral stent has the same safety and efficacy as the standard ureteral stent, and is significantly better than the standard ureteral stent in flank pain and suprapubic pain, VAS, analgesic used after hospitalization, back soreness during micturition, and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Zitieren
APA
Zhang, Y., Chen, C., Hu, W., Li, S., Li, Y., & Zhu, R. (2023). Antireflux Ureteral Stent Improves Stent-Related Symptoms and Quality of Life: A Prospective Randomized Controlled Trial. Journal of Endourology. https://doi.org/10.1089/end.2022.0839
Vancouver
Zhang Y, Chen C, Hu W, Li S, Li Y, Zhu R. Antireflux Ureteral Stent Improves Stent-Related Symptoms and Quality of Life: A Prospective Randomized Controlled Trial. Journal of Endourology. 2023. doi:10.1089/end.2022.0839
BibTeX
@article{Zhang2023,
author = {Zhang, Yuqing and Chen, Changqing and Hu, Wei and Li, Simin and Li, Yang and Zhu, Rujian},
title = {Antireflux Ureteral Stent Improves Stent-Related Symptoms and Quality of Life: A Prospective Randomized Controlled Trial},
journal = {Journal of Endourology},
year = {2023},
doi = {10.1089/end.2022.0839}
}
EUVIMED